2005Zhongguo jiceng yiyaoRequires access

A clinical study of transcatheter arterial chemoembolization(TACE) combined with three-dimensional conformal radiotherapy(3DCRT) in hepatocellular carcinoma(HCC)

Mai Da-ha

Open publisher page 0 citations

Abstract

Objective To evaluate the clinical effect of combined transcatheter arterial chemoembolization(TACE) and three-dimensional conformal radiotherapy(3DCRT) for hepatocellular carcinoma(HCC).Methods 30 cases of HCC were divided into 2 groups,15 cases treated with a combination of TACE and 3DCRT,the other with TACE.Results The percentage of TSR(PR+MR) was 66.67% in the treated group,40% in the control group.The difference was significant(P0.05).The percentage of AFP declined was 100% in the treated group,86.67% in the control group.The difference was significant(P0.05).The cumulate survival rate of 6 months,1 year and 2 years in the treated group were 100.00%(15/15),60.00%(9/15),33.33%(5/15),and 80.00%(12/15),33.33%(5/15),20%(3/15) in the control group respectively.The median survival time of the treated group was 18.5 months,and in the control group was 10 months.Conclusion The clinical effect of TACE combined with 3DCRT is better than single TACE in the near future.

About this research paper

What this paper is about

Objective To evaluate the clinical effect of combined transcatheter arterial chemoembolization(TACE) and three-dimensional conformal radiotherapy(3DCRT) for hepatocellular carcinoma(HCC).Methods 30 cases of HCC were divided into 2 groups,15 cases treated with a combination of TACE and 3DCRT,the other with TACE.Results The percentage of TSR(PR+MR) was 66.67% in the treated group,40% in the control group.The difference was significant(P0.05).The percentage of AFP declined was 100% in the treated group,86.67% in the control group.The difference was significant(P0.05).The cumulate survival rate of 6 months,1 year and 2 years in the treated group were 100.00%(15/15),60.00%(9/15),33.33%(5/15),and 80.00%(12/15),33.33%(5/15),20%(3/15) in the control group respectively.The median survival time of the treated group was 18.5 months,and in the control group was 10 months.Conclusion The clinical effect of TACE combined with 3DCRT is better than single TACE in the near future.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Objective To evaluate the clinical effect of combined transcatheter arterial chemoembolization(TACE) and three-dimensional conformal radiotherapy(3DCRT) for hepatocellular carcinoma(HCC).Methods 30 cases of HCC were divided into 2 groups,15 cases treated with a combination of TACE and 3DCRT,the other with TACE.Results The percentage of TSR(PR+MR) was 66.67% in the treated group,40% in the control group.The difference was significant(P0.05).The percentage of AFP declined was 100% in the treated group,86.67% in the control group.The difference was significant(P0.05).The cumulate survival rate of 6 months,1 year and 2 years in the treated group were 100.00%(15/15),60.00%(9/15),33.33%(5/15),and 80.00%(12/15),33.33%(5/15),20%(3/15) in the control group respectively.The median survival time of the treated group was 18.5 months,and in the control group was 10 months.Conclusion The clinical effect of TACE combined with 3DCRT is better than single TACE in the near future.

Key concepts: Medicine, Hepatocellular carcinoma, Transcatheter arterial chemoembolization, Significant difference, Gastroenterology, Internal medicine, Radiation therapy, Radiology

Related papers

Back to paper searchBrowse research topicsOriginal source
A clinical study of transcatheter arterial chemoembolization(TACE) combined with three-dimensional conformal radiotherapy(3DCRT) in hepatocellular carcinoma(HCC) — Research Paper | ScholarLens